Monday, June 8, 2026

pharma

Bracco International

Bracco International is a pharma organization headquartered in Amsterdam, NL. NovaPharmaNews links 0 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov,

Amsterdam, NL HQ
Public company Type
Company details
Status
Public
HQ
Amsterdam, NL
Programs
0
Drugs
0
Patents
25
Intelligence Β· Patents

Bracco International patents

25 pharmaceutical patents indexed for Bracco International. 7 expire within 24 months.

Bracco International has 25 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 7 expire within 24 months β€” use filters for patent-cliff planning.

Patent portfolio

  1. IL 172160

    Method for non-invasive quantification of perfusion in a tissue

    Expires Wed Apr 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. EP 2117603

    TARGETING UND THERAPEUTISCHE VERBINDUNGEN UND GASGEFÜLLTE MIKROVESIKEL MIT DIESEN VERBINDUNGEN

    Expires Tue Nov 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. WO 2009076388

    CONJUGUÉS VECTEUR DE CIBLAGE - PHOSPHOLIPIDE

    Expires Wed Jun 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. CA 2670932

    DETECTION DU DETACHEMENT D'UN AGENT DE CONTRASTE IMMOBILISE DANS DES APPLICATIONS D'IMAGERIE MEDICALE

    Expires Wed Jun 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 2008107607

    TARGETING VECTOR-PHOSPHOLIPID CONJUGATES

    Expires Wed May 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 2008063603

    ULTRASOUND CONTRAST AGENTS AND METHODS OF MAKING AND USING THEM

    Expires Wed Mar 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. CA 2631716

    CONJUGUES VECTEUR DE CIBLAGE-PHOSPHOLIPIDES

    Expires Wed Jun 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 2007128117

    Ultrasound contrast agents and process for the preparation thereof

    Expires Wed Jun 02 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 2007086944

    CONJUGATES OF ANTIOXIDANTS WITH METAL CHELATING LIGANDS FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

    Expires Wed Apr 14 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 2006153775

    Compounds for targeting endothelial cells, compositions containing the same and methods for their use

    Expires Wed Jul 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US RE39146

    Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof

    Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. WO 2006031885

    PEPTIDES DE LIAISON A LA REGION DU DOMAINE KINASE (KDR) ET AU COMPLEXE FACTEUR DE CROISSANCE ENDOTHELIALE VASCULAIRE/REGION DU DOMAINE KINASE (VEGF/KDR)

    Expires Wed Mar 18 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  13. EP 1603935

    SPEZIFISCH AN HGF-REZEPTOR (cMet) BINDENDE PEPTIDE UND DEREN VERWENDUNG

    Expires Tue Dec 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  14. EP 1590006

    ULTRASCHALL KONTRASTMITTEL UND VERFAHREN ZUR ERSTELLUNG

    Expires Tue Oct 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  15. US 2005147555

    Methods for preparing multivalent constructs for therapeutic and diagnostic applications and methods of preparing the same

    Expires Wed Jul 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  16. US 2004208826

    Ultrasound contrast agents and methods of making and using them

    Expires Wed Oct 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  17. US 2004170566

    Dual functioning excipient for metal chelate contrast agents

    Expires Wed Aug 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  18. CA 2512780

    PRODUITS DE SYNTHESE MULTIVALENTS POUR APPLICATIONS THERAPEUTIQUES ET DIAGNOSTIQUES

    Expires Wed Jul 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  19. CA 2513044

    PEPTIDES DE LIAISON KDR ET VEGF/KDR ET LEUR UTILISATION A DES FINS DIAGNOSTIQUES ET THERAPEUTIQUES

    Expires Wed Jul 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  20. US 2004033243

    SINCALIDE FORMULATIONS

    Expires Wed Feb 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  21. US 2003194376

    Ultrasound contrast agents and methods of making and using them

    Expires Wed Oct 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  22. CA 2477935

    PRODUITS DE SYNTHESE MULTIVALENTS POUR APPLICATIONS THERAPEUTIQUES ET DIAGNOSTIQUES

    Expires Wed Oct 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  23. US 2003185759

    Ultrasound contrast agents and methods of making and using them

    Expires Wed Sep 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  24. US 2003175211

    Ultrasound contrast agents and methods of making and using them

    Expires Wed Sep 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  25. CA 2477836

    PEPTIDES LIANT DES RECEPTEURS KDR ET VEGF/KDR ET LEURS UTILISATIONS EN DIAGNOSTIC ET THERAPIE

    Expires Thu Sep 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Bracco International have?

25 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Bracco International patents expire?

7 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.